Literature DB >> 16619528

Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.

Anastasia A Beklemisheva1, Yuqiang Fang, Jingyang Feng, Xudong Ma, Wei Dai, Jen Wei Chiao.   

Abstract

BACKGROUND: Isothiocyanates, the constituents of cruciferous vegetables, may be able to prevent prostate cancer. The hypothesis that they could remodel chromatins and activate cell cycle inhibitors, such as p21 for growth inhibition, was tested.
MATERIALS AND METHODS: Prostate cancer LNCaP cells were exposed to phenylhexyl isothiocyanate (PHI). The status of histone acetylation and the activity of histone deacetylases (HDAC) were investigated. The association of p21 with hyperacetylated histones was examined by chromatin immunoprecipitation.
RESULTS: The PHI-exposed LNCaP cells had diminished activity of HDAC 1 and 2. Global and selective histone acetylation was enhanced, consistent with the signs of chromatin unfolding. The hyperacetylated histones increased accessibility to the p21 promoter for transcription, leading to G1 arrest and apoptosis.
CONCLUSION: PHI inhibited the activity of HDAC and remodeled chromatins to activate p21 for cell cycle arrest, underlying an epigenetic mechanism regulating the growth of prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619528

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

Review 1.  Dietary factors and epigenetic regulation for prostate cancer prevention.

Authors:  Emily Ho; Laura M Beaver; David E Williams; Roderick H Dashwood
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

Review 2.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

Authors:  Alexander Link; Francesc Balaguer; Ajay Goel
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 5.858

Review 3.  Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.

Authors:  Yifeng Gao; Trygve O Tollefsbol
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

4.  Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.

Authors:  Sarandeep S S Boyanapalli; Wenji Li; Francisco Fuentes; Yue Guo; Christina N Ramirez; Ximena-Parades Gonzalez; Douglas Pung; Ah-Ng Tony Kong
Journal:  Pharmacol Res       Date:  2016-11-03       Impact factor: 7.658

5.  Synergistic effects of phenylhexyl isothiocyanate and LY294002 on the PI3K/Akt signaling pathway in HL-60 cells.

Authors:  Huicong Yang; Yiqun Huang; Yong Zou; Xudong Ma
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

Review 6.  Isothiocyanates: a class of bioactive metabolites with chemopreventive potential.

Authors:  Gaurav Kumar; Hardeep Singh Tuli; Sonam Mittal; Jitendra Kumar Shandilya; Anil Tiwari; Sardul Singh Sandhu
Journal:  Tumour Biol       Date:  2015-04-03

Review 7.  Epigenetic diet: impact on the epigenome and cancer.

Authors:  Tabitha M Hardy; Trygve O Tollefsbol
Journal:  Epigenomics       Date:  2011-08       Impact factor: 4.778

Review 8.  Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors.

Authors:  Eunah Kim; William H Bisson; Christiane V Löhr; David E Williams; Emily Ho; Roderick H Dashwood; Praveen Rajendran
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 9.  The role of histone deacetylases in prostate cancer.

Authors:  Ata Abbas; Sanjay Gupta
Journal:  Epigenetics       Date:  2008-11-24       Impact factor: 4.528

10.  Synergistic effect of paclitaxel and epigenetic agent phenethyl isothiocyanate on growth inhibition, cell cycle arrest and apoptosis in breast cancer cells.

Authors:  Katherine Liu; Shundong Cang; Yuehua Ma; Jen Wei Chiao
Journal:  Cancer Cell Int       Date:  2013-02-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.